Matrix metalloproteinase 11 vaccine

Details for Australian Patent Application No. 2006301582 (hide)

Owner Istituto Di Ricerche Di Biologia Molecolare P Angeletti SPA

Inventors Ciliberto, Gennaro; Mori, Federica; La Monica, Nicola; Lazzaro, Domenico; Aurisicchio, Luigi; Peruzzi, Daniela

Agent Spruson & Ferguson

Pub. Number AU-B-2006301582

PCT Pub. Number WO2007/042169

Priority 60/724,498 07.10.05 US

Filing date 3 October 2006

Wipo publication date 19 April 2007

Acceptance publication date 13 October 2011

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/042169 Priority application(s): WO2007/042169

13 October 2011 Application Accepted

  Published as AU-B-2006301582

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301587-Cold-workable laminate for blister bottom parts

2006301579-EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases